4//SEC Filing
Patil Neena M 4
Accession 0001765581-25-000008
CIK 0001232524other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 7:18 PM ET
Size
8.8 KB
Accession
0001765581-25-000008
Insider Transaction Report
Form 4
Patil Neena M
EVP & Chief Legal Officer
Transactions
- Sale
Ordinary Shares
2025-02-27$144.87/sh−3,800$550,506→ 33,318 total - Award
Ordinary Shares
2025-02-27+12,518→ 45,836 total - Award
Ordinary Shares
2025-02-27+5,778→ 51,614 total
Footnotes (3)
- [F1]Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $144.81 to $144.88. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- [F2]These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2025, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years.
- [F3]These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units will vest in full on June 30, 2026.
Documents
Issuer
Jazz Pharmaceuticals plc
CIK 0001232524
Entity typeother
Related Parties
1- filerCIK 0001783908
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 7:18 PM ET
- Size
- 8.8 KB